ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF)

0.12
0.00
( 0.00% )
Updated: 19:00:00

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.12
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.000001 52 Week Range 0.35
Market Cap
Previous Close
0.12
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
28,467
Shares Outstanding
120,377,529
Dividend Yield
-
PE Ratio
-2.52
Earnings Per Share (EPS)
-0.05
Revenue
35.43M
Net Profit
-5.74M

About Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed... Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed via its dedicated sales force and digital technology mySYNCH in the USA and Australia-New Zealand, and via distributors in other markets. Parnell has a rapidly growing contract manufacturing business supplying industry majors with specialized sterile injectable products. In companion animal, Parnell manufactures and markets its proprietary canine osteoarthritis brands Zydax and Glyde. For more information on the company and its products, please visit www.parnell.com. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Sydney, New South Wales, Aus
Founded
-
Parnell Pharmaceuticals Holdings Ltd (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker PARNF. The last closing price for Parnell Pharmaceuticals (CE) was $0.12. Over the last year, Parnell Pharmaceuticals (CE) shares have traded in a share price range of $ 0.000001 to $ 0.35.

Parnell Pharmaceuticals (CE) currently has 120,377,529 shares outstanding. The market capitalization of Parnell Pharmaceuticals (CE) is $14.45 million. Parnell Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of -2.52.

PARNF Latest News

Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ

OVERLAND PARK, Kan., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...

OVERLAND PARK, Kan., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility

OVERLAND PARK, Kan., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016

OVERLAND PARK, Kansas, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016

OVERLAND PARK, Kan., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016

OVERLAND PARK, Kan., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016

OVERLAND PARK, Kan., July 26, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial

OVERLAND PARK, Kan., May 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock

OVERLAND PARK, Kan., May 12, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update

Parnell continues to grow rapidly with revenue increasing 43% for the three months ended March 31, 2016OVERLAND PARK, Kan., April 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.120.120.125000.12CS
40.03846.34146341460.0820.180.082195800.1423284CS
120.071400.050.350.05284670.08767723CS
260.11991199000.00010.351.0E-6206910.08616385CS
520.119999119999001.0E-60.351.0E-6148680.08393423CS
1560.11991199000.00010.351.0E-6133180.02880215CS
2600.029933.18534961150.09010.891.0E-6124140.21483978CS

PARNF - Frequently Asked Questions (FAQ)

What is the current Parnell Pharmaceuticals (CE) share price?
The current share price of Parnell Pharmaceuticals (CE) is $ 0.12
How many Parnell Pharmaceuticals (CE) shares are in issue?
Parnell Pharmaceuticals (CE) has 120,377,529 shares in issue
What is the market cap of Parnell Pharmaceuticals (CE)?
The market capitalisation of Parnell Pharmaceuticals (CE) is USD 14.45M
What is the 1 year trading range for Parnell Pharmaceuticals (CE) share price?
Parnell Pharmaceuticals (CE) has traded in the range of $ 0.000001 to $ 0.35 during the past year
What is the PE ratio of Parnell Pharmaceuticals (CE)?
The price to earnings ratio of Parnell Pharmaceuticals (CE) is -2.52
What is the cash to sales ratio of Parnell Pharmaceuticals (CE)?
The cash to sales ratio of Parnell Pharmaceuticals (CE) is 0.41
What is the reporting currency for Parnell Pharmaceuticals (CE)?
Parnell Pharmaceuticals (CE) reports financial results in AUD
What is the latest annual turnover for Parnell Pharmaceuticals (CE)?
The latest annual turnover of Parnell Pharmaceuticals (CE) is AUD 35.43M
What is the latest annual profit for Parnell Pharmaceuticals (CE)?
The latest annual profit of Parnell Pharmaceuticals (CE) is AUD -5.74M
What is the registered address of Parnell Pharmaceuticals (CE)?
The registered address for Parnell Pharmaceuticals (CE) is UNIT 4 CENTURY ESTATE, 476 GARDENERS ROAD, ALEXANDRIA, SYDNEY, NEW SOUTH WALES, 2015
What is the Parnell Pharmaceuticals (CE) website address?
The website address for Parnell Pharmaceuticals (CE) is www.parnell.com
Which industry sector does Parnell Pharmaceuticals (CE) operate in?
Parnell Pharmaceuticals (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BWVIBlue Water Ventures International Inc (CE)
$ 0.0004
(39,900.00%)
10k
KBNTKubient Inc (CE)
$ 0.0003
(29,900.00%)
10.1k
CHWEChinawe Com Inc (CE)
$ 0.0003
(29,900.00%)
1,000
ELYSElys BMG Group Inc (CE)
$ 0.1002
(24,950.00%)
750
NBRVFNabriva Therapeutics PLC (CE)
$ 0.0002
(19,900.00%)
127
CTRYFCountry Garden Holdings Company Limited (CE)
$ 0.0002
(-99.89%)
2.25k
CAUDCollective Audience Inc (CE)
$ 0.0003
(-99.88%)
348
CNQQFClean TeQ Water Ltd (PK)
$ 0.0007
(-99.88%)
300
FGHFFForte Group Holdings Inc (PK)
$ 0.0013
(-99.67%)
212
MGTIMGT Capital Investments Inc (CE)
$ 0.000001
(-99.67%)
1.5k
GRLFGreen Leaf Innovations Inc (PK)
$ 0.0001
(0.00%)
131.54M
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.00335
(1.52%)
72.42M
SPQSSportsQuest Inc (PK)
$ 0.00045
(-10.00%)
61.39M
RONNRonn Motor Group Inc (PK)
$ 0.0003
(-25.00%)
60.25M
GTVHGolden Triangle Ventures Inc (PK)
$ 0.0004
(0.00%)
54.5M

Discussion

View Full Feed
ShadowHaven59 ShadowHaven59 2 minutes ago
How and why did this analyst give this company a double digit price target after speaking to the company? this is very frustrating.
MRKR
BigBadWolf BigBadWolf 2 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175674466&txt2find=painfully
RDAR
BBANBOB BBANBOB 2 minutes ago
I'd glady come harvest a COW elk ifin they need thinning out
COOP
jour_trader jour_trader 2 minutes ago
Many years ago I recall Nasrat mentioning a company that was going to try and run Elite into the ground. Can't remember if this was a company that wanted to buy Elite or what. Was many, many years ago. Doubt it's the same company.  Running share price into ground has no impact on Elite unless they a
ELTP
ThunderousSeer8 ThunderousSeer8 2 minutes ago
I saw it before he was able 😂😂 He knows only desperation.
RDAR
Huggy Bear Huggy Bear 2 minutes ago
The world I live in called reality.

Family of 5 saw it and many other who commented as such right before the new fairy tales were launched.
HMBL
lager lager 2 minutes ago
Good prices here. Get 'em while they last.
MGON
sab63090 sab63090 2 minutes ago
Leo

I agree seems like fairly low volume, RSI below 50, MACD down....market trying to feel out a low, notice that we are dancing right around the 50 day sma which is a hopeful support, only a positive push high on volume would encourage even a 50 cent trader.
AVXL
bas2020 bas2020 3 minutes ago
Again... you're fooling no one. 👿☠️
NWBO
Investor2014 Investor2014 3 minutes ago
Quite true.

“Everyone but SAVA investors were right about SAVA's data.”

Obviously this can’t possibly be the case regarding WGT AVXL investors right?

Or was your statement based in some law I’m just unfamiliar with?
AVXL
ysung ysung 3 minutes ago
Yes yes it's happening fast !!!!!!

https://stocktwits.com/StocktwitsCrypto/message/600876524
XRPUSD
FOFreddie FOFreddie 3 minutes ago
There is no way to interpret Bessents response other than the GSEs are going to be released. Check out Questions 68 to 84. It all comes down to being briefed by the UST Staff and working with the FHFA Director. He commits to work with Congress but as Laurie Goodman has already stated in the Urb
FNMA
delerious1 delerious1 3 minutes ago
I see HGRAF up 24% and quite a few other H2's are Green today....( HG up 26%) surprising
HGRAF
dewophile dewophile 4 minutes ago
I never saw this much success coming. They essentially have a branded generic and just did an amazing job with marketing (essentially competing on price) in a very competitive environment without any advantage over existing products clinically
MartinLutherKing MartinLutherKing 4 minutes ago
Gap fill .65 up next brothers
FOXO
LetGoodTimesRoll LetGoodTimesRoll 4 minutes ago
$FOXO steady. $RNVA steady. 
All the credible hype continues to go from... 
"it's go time", to "wait wait, wait". 
RNVA!!$$$$$$$$🤣😂
FOXO RNVA
jimr1717 jimr1717 4 minutes ago
Tesla Model 3 earns 5-star rating 🏆️ in Green NCAP test.
The Tesla Model 3 has aced the Green NCAP test, earning a 5-star safety rating with an average score of 98%.

As per the Green NCAP, the Model 3 proved to be one of the most energy-efficient vehicles it has ever te
TSLA
vlispxpert vlispxpert 4 minutes ago
last 4 picks are Years long...good luck
Jim Beem Jim Beem 4 minutes ago
crazy dumping... .0003s not far away





In my opinion
ASII
vlispxpert vlispxpert 5 minutes ago
CAKE long
ysung ysung 5 minutes ago
style="border: 0 solid rgba(229, 231, 235, 1); display: block"January 21, 2025 12:44 PM style="border-t
XRPUSD
Golden Cross Golden Cross 5 minutes ago
$WKSP $2,900,000 for Q4 2024, marking a significant improvement from $839,000 in Q4 2023. This strong performance pushes Worksport’s year-end revenues to approximately $8,500,000, beating the Company’s previously announced guidance range of $6–8 million for 2024.
https://stocktitan.net/news/W
WKSP
IH Geek [Sherlock] IH Geek [Sherlock] 5 minutes ago
For push notifications, our dev team is actively working to bring it back, so that should be sorted in next updates. For the rest, I'll make sure to include in our plans so we can sort all of it. Thank you for the feedback. 
Juntao Juntao 5 minutes ago
$TORVF https://www.otcmarkets.com/stock/TORVF/news/story?e&id=3109334
TORVF

Your Recent History

Delayed Upgrade Clock